Health
Cigarette maker BAT announces US vaccine trial launch – Medical Xpress
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed…
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.
The group said the US Food and Drug Administration has approved its application for a vaccine candidate, paving the way for an initial phase one clinical trial in 180 adults.
Study results are expected in mid-2021, when the group hopes to progress to a phase two trial on the project, which is being run on a…
-
General21 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News17 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News10 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General10 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final